117 related articles for article (PubMed ID: 24841650)
1. Effect of variation of ABCB1 and GSTP1 on osteosarcoma survival after chemotherapy.
Li JZ; Tian ZQ; Jiang SN; Feng T
Genet Mol Res; 2014 Apr; 13(2):3186-92. PubMed ID: 24841650
[TBL] [Abstract][Full Text] [Related]
2. Predictive potential of ABCB1, ABCC3, and GSTP1 gene polymorphisms on osteosarcoma survival after chemotherapy.
Liu S; Yi Z; Ling M; Shi J; Qiu Y; Yang S
Tumour Biol; 2014 Oct; 35(10):9897-904. PubMed ID: 24996541
[TBL] [Abstract][Full Text] [Related]
3. Effect of variation of ABCB1 and ABCC3 genotypes on the survival of bone tumor cases after chemotherapy.
Yang J; Wang ZG; Cai HQ; Li YC; Xu YL
Asian Pac J Cancer Prev; 2013; 14(8):4595-8. PubMed ID: 24083708
[TBL] [Abstract][Full Text] [Related]
4. Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma: a pilot study.
Windsor RE; Strauss SJ; Kallis C; Wood NE; Whelan JS
Cancer; 2012 Apr; 118(7):1856-67. PubMed ID: 21887680
[TBL] [Abstract][Full Text] [Related]
5. Glutathione S-transferase P1 and DNA polymorphisms influence response to chemotherapy and prognosis of bone tumors.
Yang LM; Li XH; Bao CF
Asian Pac J Cancer Prev; 2012; 13(11):5883-6. PubMed ID: 23317281
[TBL] [Abstract][Full Text] [Related]
6. Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.
Caronia D; Patiño-García A; Milne RL; Zalacain-Díez M; Pita G; Alonso MR; Moreno LT; Sierrasesumaga-Ariznabarreta L; Benítez J; González-Neira A
Pharmacogenomics J; 2009 Oct; 9(5):347-53. PubMed ID: 19434073
[TBL] [Abstract][Full Text] [Related]
7. Predictive potential of glutathione S-transferase polymorphisms for prognosis of osteosarcoma patients on chemotherapy.
Zhang SL; Mao NF; Sun JY; Shi ZC; Wang B; Sun YJ
Asian Pac J Cancer Prev; 2012; 13(6):2705-9. PubMed ID: 22938445
[TBL] [Abstract][Full Text] [Related]
8. Predictive impact of common variations in DNA repair genes on clinical outcome of osteosarcoma.
Bai SB; Chen HX; Bao YX; Luo X; Zhong JJ
Asian Pac J Cancer Prev; 2013; 14(6):3677-80. PubMed ID: 23886164
[TBL] [Abstract][Full Text] [Related]
9. Functional glutathione S-transferase genotypes among testicular germ cell tumor survivors: associations with primary and post-chemotherapy tumor histology.
Kraggerud SM; Oldenburg J; Alnaes GI; Berg M; Kristensen VN; Fossa SD; Lothe RA
Pharmacogenet Genomics; 2009 Oct; 19(10):751-9. PubMed ID: 19741569
[TBL] [Abstract][Full Text] [Related]
10. Influence of the folate pathway and transporter polymorphisms on methotrexate treatment outcome in osteosarcoma.
Goričar K; Kovač V; Jazbec J; Zakotnik B; Lamovec J; Dolžan V
Pharmacogenet Genomics; 2014 Oct; 24(10):514-21. PubMed ID: 25098908
[TBL] [Abstract][Full Text] [Related]
11. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer.
Kalikaki A; Kanaki M; Vassalou H; Souglakos J; Voutsina A; Georgoulias V; Mavroudis D
Clin Lung Cancer; 2009 Mar; 10(2):118-23. PubMed ID: 19362955
[TBL] [Abstract][Full Text] [Related]
12. ABCB1 and GST polymorphisms associated with TP53 status in breast cancer.
Nordgard SH; Ritchie MD; Jensrud SD; Motsinger AA; Alnaes GI; Lemmon G; Berg M; Geisler S; Moore JH; Lønning PE; Børresen-Dale AL; Kristensen VN
Pharmacogenet Genomics; 2007 Feb; 17(2):127-36. PubMed ID: 17301692
[TBL] [Abstract][Full Text] [Related]
13. GSTT1, GSTM1, and GSTP1 polymorphisms as a prognostic factor in women with breast cancer.
Oliveira AL; Oliveira Rodrigues FF; Dos Santos RE; Rozenowicz RL; Barbosa de Melo M
Genet Mol Res; 2014 Jan; 13(2):2521-30. PubMed ID: 24535908
[TBL] [Abstract][Full Text] [Related]
14. Single nucleotide polymorphisms in the NER pathway and clinical outcome of patients with bone malignant tumors.
Sun XH; Hou WG; Zhao HX; Zhao YL; Ma C; Liu Y
Asian Pac J Cancer Prev; 2013; 14(3):2049-52. PubMed ID: 23679317
[TBL] [Abstract][Full Text] [Related]
15. Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy.
Hawkins DS; Arndt CA
Cancer; 2003 Dec; 98(11):2447-56. PubMed ID: 14635080
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic features of osteosarcoma in patients with Rothmund-Thomson syndrome.
Hicks MJ; Roth JR; Kozinetz CA; Wang LL
J Clin Oncol; 2007 Feb; 25(4):370-5. PubMed ID: 17264332
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139.
Zalupski MM; Rankin C; Ryan JR; Lucas DR; Muler J; Lanier KS; Budd GT; Biermann JS; Meyers FJ; Antman K
Cancer; 2004 Feb; 100(4):818-25. PubMed ID: 14770440
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of SOD2 and GSTP1 gene polymorphisms in Chinese patients with gastric cancer.
Xu Z; Zhu H; Luk JM; Wu D; Gu D; Gong W; Tan Y; Zhou J; Tang J; Zhang Z; Wang M; Chen J
Cancer; 2012 Nov; 118(22):5489-96. PubMed ID: 22517484
[TBL] [Abstract][Full Text] [Related]
19. Relationship between glutathione S-transferase P1 (GSTP1), X-ray repair cross complementing group 1 (XRCC1) and 5,10-methylenetetrahydrofolate reductase (5,10-MTHFR) gene polymorphisms and response to chemotherapy in advanced gastric cancer.
Ji M; Xu B; Jiang JT; Wu J; Li XD; Zhao WQ; Zhang HY; Zhou WJ; Wu CP
Onkologie; 2013; 36(6):335-40. PubMed ID: 23774147
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma.
Uchibori M; Nishida Y; Nagasaka T; Yamada Y; Nakanishi K; Ishiguro N
Int J Oncol; 2006 Jan; 28(1):33-42. PubMed ID: 16327977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
